Cardiac Magnetic Resonance Assessment of Myocardial Steatosis

2017 ◽  
Author(s):  
Lisa Gillinder
Keyword(s):  
Cardiac Magnetic Resonance ◽  
Magnetic Resonance ◽  
Myocardial Steatosis

scholarly journals Cardiac magnetic resonance imaging: insights into developmental programming and its consequences for aging

2020 ◽  
pp. 1-17
Author(s):  
G.D. Clarke ◽  
J. Li ◽  
A.H. Kuo ◽  
A.J. Moody ◽  
P.W. Nathanielsz
Keyword(s):  
Magnetic Resonance Imaging ◽  
Cardiac Magnetic Resonance ◽  
Magnetic Resonance ◽  
Cardiac Magnetic Resonance Imaging ◽  
Ventricular Remodeling ◽  
Developmental Programming ◽  
Resonance Imaging ◽  
Current State ◽  
Baboon Model ◽  
Myocardial Steatosis

Abstract Cardiovascular diseases (CVD) are important consequences of adverse perinatal conditions such as fetal hypoxia and maternal malnutrition. Cardiac magnetic resonance imaging (CMR) can produce a wealth of physiological information related to the development of the heart. This review outlines the current state of CMR technologies and describes the physiological biomarkers that can be measured. These phenotypes include impaired ventricular and atrial function, maladaptive ventricular remodeling, and the proliferation of myocardial steatosis and fibrosis. The discussion outlines the applications of CMR to understanding the developmental pathways leading to impaired cardiac function. The use of CMR, both in animal models of developmental programming and in human studies, is described. Specific examples are given in a baboon model of intrauterine growth restriction (IUGR). CMR offers great potential as a tool for understanding the sequence of dysfunctional adaptations of developmental origin that can affect the human cardiovascular system.

Cardiac evaluation in turner syndrome: echocardiography versus cardiac magnetic resonance

2018 ◽  
Author(s):  
Matilde Calanchini ◽  
Elizabeth Orchard ◽  
Saul Myerson ◽  
Fiona McMillan ◽  
Jason Bradley-Watson ◽  
...  
Keyword(s):  
Cardiac Magnetic Resonance ◽  
Magnetic Resonance ◽  
Turner Syndrome ◽  
Cardiac Evaluation

Cardiac Magnetic Resonance Blood Pool Contrast Agents

2007 ◽  
Vol 3 (2) ◽  
pp. 38
Author(s):  
Covadonga Fernández-Golfín ◽  
José Luis Zamorano ◽  
◽  
Keyword(s):  
Cardiac Magnetic Resonance ◽  
Magnetic Resonance ◽  
Contrast Agents ◽  
Blood Pool ◽  
Blood Pool Contrast Agents

Diagnosis and Management of Cardiomyopathies – A Focus on Genetics, Cardiac Magnetic Resonance and Clinical Features

2011 ◽  
Vol 7 (3) ◽  
pp. 225
Author(s):  
Gianfranco Sinagra ◽  
Michele Moretti ◽  
Giancarlo Vitrella ◽  
Marco Merlo ◽  
Rossana Bussani ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Cardiac Magnetic Resonance ◽  
Magnetic Resonance ◽  
Imaging Techniques ◽  
Molecular Genetic ◽  
Molecular Genetic Analysis ◽  
Routine Clinical Practice ◽  
Clinical Approach ◽  
Diagnosis And Management ◽  
Made In

In recent years, outstanding progress has been made in the diagnosis and treatment of cardiomyopathies. Genetics is emerging as a primary point in the diagnosis and management of these diseases. However, molecular genetic analyses are not yet included in routine clinical practice, mainly because of their elevated costs and execution time. A patient-based and patient-oriented clinical approach, coupled with new imaging techniques such as cardiac magnetic resonance, can be of great help in selecting patients for molecular genetic analysis and is crucial for a better characterisation of these diseases. This article will specifically address clinical, magnetic resonance and genetic aspects of the diagnosis and management of cardiomyopathies.

Sign in / Sign up

Export Citation Format

Share Document